These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6281776)
1. Cell surface properties of HLA antigens on Epstein-Barr virus-transformed cell lines. Smith LM; Petty HR; Parham P; McConnell HM Proc Natl Acad Sci U S A; 1982 Jan; 79(2):608-12. PubMed ID: 6281776 [TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. Kabelitz D; Janssen O Cell Immunol; 1989 Apr; 120(1):21-30. PubMed ID: 2467753 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
4. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes. Brodsky FM Immunogenetics; 1984; 19(3):179-94. PubMed ID: 6200433 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells. Newman RA; Delia D; Greaves MF; Navarrete C; Fainboim L; Festenstein H Eur J Immunol; 1983 Feb; 13(2):172-6. PubMed ID: 6187581 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens. Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617 [TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity against HLA-A, HLA-B and HLA-DR specificities. Akiyama N; Ohsawa N; Kano K Int Arch Allergy Appl Immunol; 1984; 74(3):286-8. PubMed ID: 6327536 [TBL] [Abstract][Full Text] [Related]
8. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
9. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report. Hulette CM; Effros RB; Dillard LC; Walford RL Am J Pathol; 1985 Oct; 121(1):10-4. PubMed ID: 2996358 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of human leucocyte antigen expression during culture of Epstein-Barr virus-transformed cell lines using the dako QIFIKIT. Battle R; Clark B Br J Biomed Sci; 2007; 64(1):32-4. PubMed ID: 17444417 [TBL] [Abstract][Full Text] [Related]
11. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus. Sugden B; Metzenberg S J Virol; 1983 Jun; 46(3):800-7. PubMed ID: 6304342 [TBL] [Abstract][Full Text] [Related]
12. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies. Odum N; Ledbetter JA; Martin P; Geraghty D; Tsu T; Hansen JA; Gladstone P Eur J Immunol; 1991 Sep; 21(9):2121-31. PubMed ID: 1889460 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation of human leukocyte locus A molecules is dependent on the cell type. Merlu B; Neel D; Goussault Y; Charron DJ Eur J Biochem; 1989 May; 181(3):755-60. PubMed ID: 2543568 [TBL] [Abstract][Full Text] [Related]
16. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells. Gallagher G; Stimson WH Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205 [TBL] [Abstract][Full Text] [Related]
17. Specificity of monoclonal antibodies to an EBV transformed B-cell line. Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556 [TBL] [Abstract][Full Text] [Related]
18. Lateral mobility of class I histocompatibility antigens in B lymphoblastoid cell membranes: modulation by cross-linking and effect of cell density. Bierer BE; Herrmann SH; Brown CS; Burakoff SJ; Golan DE J Cell Biol; 1987 Sep; 105(3):1147-52. PubMed ID: 3115995 [TBL] [Abstract][Full Text] [Related]
19. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes. Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266 [TBL] [Abstract][Full Text] [Related]
20. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]